These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 16132579)
21. CD 9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma. Williams AA; Higgins JP; Zhao H; Ljunberg B; Brooks JD BMC Clin Pathol; 2009 Nov; 9():9. PubMed ID: 19922654 [TBL] [Abstract][Full Text] [Related]
22. Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays. Rodenhiser DI; Andrews J; Kennette W; Sadikovic B; Mendlowitz A; Tuck AB; Chambers AF Breast Cancer Res; 2008; 10(4):R62. PubMed ID: 18638373 [TBL] [Abstract][Full Text] [Related]
23. Epigenetic contributions to cancer metastasis. Rodenhiser DI Clin Exp Metastasis; 2009; 26(1):5-18. PubMed ID: 18386135 [TBL] [Abstract][Full Text] [Related]
24. High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer. Rennstam K; Hedenfalk I Breast Cancer Res; 2006; 8(4):213. PubMed ID: 16895590 [TBL] [Abstract][Full Text] [Related]
25. Options available for profiling small samples: a review of sample amplification technology when combined with microarray profiling. Nygaard V; Hovig E Nucleic Acids Res; 2006; 34(3):996-1014. PubMed ID: 16473852 [TBL] [Abstract][Full Text] [Related]
27. Identification of molecular markers for metastasis-related genes in primary breast cancer cells. Mimori K; Kataoka A; Yoshinaga K; Ohta M; Sagara Y; Yoshikawa Y; Ohno S; Barnard GF; Mori M Clin Exp Metastasis; 2005; 22(1):59-67. PubMed ID: 16132579 [TBL] [Abstract][Full Text] [Related]
28. Comparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser microdissection and cDNA microarray. Wang L; Zhu JS; Song MQ; Chen GQ; Chen JL World J Gastroenterol; 2006 Nov; 12(43):6949-54. PubMed ID: 17109515 [TBL] [Abstract][Full Text] [Related]
29. Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer. Miyake M; Nakano K; Itoi SI; Koh T; Taki T Cancer Res; 1996 Mar; 56(6):1244-9. PubMed ID: 8640807 [TBL] [Abstract][Full Text] [Related]
30. Semaphorin-plexin signalling genes associated with human breast tumourigenesis. Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246 [TBL] [Abstract][Full Text] [Related]
31. [Screening of differential expression genes between primary breast cancer and its lymph node metastasis using single primer amplification of cDNA for microarray]. Hao XS; Feng YM; Zhang L; Li XQ; Niu Y; Xiao CH; Sun BC Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):385-90. PubMed ID: 15854527 [TBL] [Abstract][Full Text] [Related]
32. [Differential expression of motility-related protein-1/CD9 gene in gastric cancers and premalignant lesions]. Zhang WM; Zheng J; Xu Y; Liu WT; Li YY; Xing J; Geng X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Oct; 21(5):426-9. PubMed ID: 15476162 [TBL] [Abstract][Full Text] [Related]
33. Motility-related protein-1 (MRP-1/CD9) expression can predict disease-free survival in patients with squamous cell carcinoma of the head and neck. Mhawech P; Dulguerov P; Tschanz E; Verdan C; Ares C; Allal AS Br J Cancer; 2004 Jan; 90(2):471-5. PubMed ID: 14735195 [TBL] [Abstract][Full Text] [Related]
34. Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma. Pingoud-Meier C; Lang D; Janss AJ; Rorke LB; Phillips PC; Shalaby T; Grotzer MA Clin Cancer Res; 2003 Dec; 9(17):6401-9. PubMed ID: 14695141 [TBL] [Abstract][Full Text] [Related]
35. Motility-related protein 1 (MRP-1/CD9) expression in urothelial bladder carcinoma and its relation to tumor recurrence and progression. Mhawech P; Herrmann F; Coassin M; Guillou L; Iselin CE Cancer; 2003 Oct; 98(8):1649-57. PubMed ID: 14534881 [TBL] [Abstract][Full Text] [Related]